These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14726373)

  • 1. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.
    Rajagopalan S; Somers EC; Brook RD; Kehrer C; Pfenninger D; Lewis E; Chakrabarti A; Richardson BC; Shelden E; McCune WJ; Kaplan MJ
    Blood; 2004 May; 103(10):3677-83. PubMed ID: 14726373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction.
    El Solh AA; Akinnusi ME; Baddoura FH; Mankowski CR
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1186-91. PubMed ID: 17272785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.
    Cederholm A; Svenungsson E; Jensen-Urstad K; Trollmo C; Ulfgren AK; Swedenborg J; Fei GZ; Frostegård J
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):198-203. PubMed ID: 15539620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.
    Parker B; Al-Husain A; Pemberton P; Yates AP; Ho P; Gorodkin R; Teh LS; Alexander MY; Bruce IN
    Ann Rheum Dis; 2014 Jun; 73(6):1144-50. PubMed ID: 23644670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
    Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients.
    Valer P; Paul B; Eugenia B; Camelia B
    Clin Lab; 2013; 59(3-4):359-67. PubMed ID: 23724626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.
    Mak A; Liu Y; Ho RC
    J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Stalc M; Tomsic M; Jezovnik MK; Poredos P
    Clin Exp Rheumatol; 2011; 29(4):616-23. PubMed ID: 21813059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification.
    Baker JF; Zhang L; Imadojemu S; Sharpe A; Patil S; Moore JS; Mohler ER; Von Feldt J
    Rheumatol Int; 2012 Apr; 32(4):997-1002. PubMed ID: 21246370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study.
    Marder W; Somers EC; Kaplan MJ; Anderson MR; Lewis EE; McCune WJ
    Lupus; 2010 Sep; 19(10):1229-36. PubMed ID: 20530522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.